Swiss National Bank
MDLN

Swiss National Bank’s Medline Inc MDLN Stock Holding History

Swiss National Bank’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.7M Buy
+1,031,100
New +$41.5M 0.02% 492

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swiss National Bank's MDLN Position: Q2 2026 in Review

Swiss National Bank opened a new position in Medline Inc (MDLN) in Q2 2026: 1,031,100 shares worth $40.7M. The stake represents 0.02% of the portfolio and ranks #492 among its holdings.

195 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Swiss National Bank held 1,031,100 shares of Medline Inc worth $40.7M as of Q2 2026.
  • Medline Inc was a new Swiss National Bank position in Q2 2026.
  • Medline Inc made up 0.02% of Swiss National Bank's portfolio in Q2 2026, its #492 holding.
  • 195 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.